Trial Profile
Depression, Obesity and Inflammatory Markers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Minocycline (Primary)
- Indications Gram-negative infections; Gram-positive infections
- Focus Biomarker; Pharmacodynamics
- 20 Nov 2019 Status changed from recruiting to completed.
- 22 Jul 2019 Planned End Date changed from 1 Apr 2019 to 1 Oct 2019.
- 22 Jul 2019 Planned primary completion date changed from 1 Apr 2019 to 1 Oct 2019.